PPAR(alpha) and PPAR(gamma) activators suppress the monocyte-macrophage apoB-48 receptor.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Lipid Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12700342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis

  2002cited by this paper
• The murine macrophage apoB-48 receptor gene (Apob-48r): homology to the human receptor.

  2002cited by this paper
• The macrophage foam cell as a target for therapeutic intervention

  2002cited by this paper
• Scavenger Receptors, Oxidized LDL, and Atherosclerosis

  2001cited by this paper
• The role of PPAR-gamma in macrophage differentiation and cholesterol uptake.

  2001cited by this paper
• PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation

  2001cited by this paper
• PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.

  2000cited by this paper
• Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.

  2000cited by this paper
• A macrophage receptor for apolipoprotein B48: cloning, expression, and atherosclerosis.

  2000cited by this paper
• CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.

  2000cited by this paper
• Scavenger Receptor-BI Inhibits ATP-binding Cassette Transporter 1- mediated Cholesterol Efflux in Macrophages*

  2000cited by this paper
• PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.

  1998cited by this paper
• Apolipoprotein B-48 or its apolipoprotein B-100 equivalent mediates the binding of triglyceride-rich lipoproteins to their unique human monocyte-macrophage receptor.

  1998cited by this paper
• Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro.

  1998cited by this paper
• PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.

  1998cited by this paper
• The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation.

  1998cited by this paper
• Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysis.

  1996cited by this paper
• Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies

  1996cited by this paper
• Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more....

  1995cited by this paper
• Human THP-1 monocyte-macrophage membrane binding proteins: distinct receptor(s) for triglyceride-rich lipoproteins.

  1995cited by this paper
• Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications.

  1992cited by this paper
• Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

  1992cited by this paper
• Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.

  1992cited by this paper
• The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein

  1989cited by this paper
• Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins.

  1989cited by this paper
• Purification and characterization of a bovine acetyl low density lipoprotein receptor.

  1988cited by this paper
• Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.

  1988cited by this paper
• Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100

  1986cited by this paper
• A receptor-mediated pathway for cholesterol homeostasis.

  1986cited by this paper
• George Lyman Duff memorial lecture. Role of the liver in atherosclerosis.

  1985cited by this paper
• Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

  1983cited by this paper
• Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages.

  1982cited by this paper
• Abnormal effects of hypertriacylglycerolemic very low-density lipoproteins on 3-hydroxy-3-methylglutaryl-CoA reductase activity and viability of cultured bovine aortic endothelial cells.

  1980cited by this paper
• Purification of lymphocytes and platelets by gradient centrifugation.

  1968cited by this paper

• Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease

  2023cites this paper
• Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis

  2022cites this paper
• PAK1 Silencing Attenuated Proinflammatory Macrophage Activation and Foam Cell Formation by Increasing PPARγ Expression

  2021cites this paper
• Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products

  2019cites this paper
• Metabolic programming of macrophage functions and pathogens control

  2019cites this paper
• PPARα receptor expression in patients with metabolic syndrome.

  2018cites this paper
• Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis

  2018cites this paper
• PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk.

  2017cites this paper
• Activation of PPARγ does not contribute to macrophage ABCA1 expression and ABCA1-mediated cholesterol efflux to apoAI.

  2017cites this paper
• Polymorphisms of the PPAR-γ (rs1801282) and Its Coactivator (rs8192673) Have a Minor Effect on Markers of Carotid Atherosclerosis in Patients with Type 2 Diabetes Mellitus

  2016cites this paper
• Salvianolic acid B accelerated ABCA1-dependent cholesterol efflux by targeting PPAR-γ and LXRα.

  2015cites this paper
• Fine Mapping of a GWAS-Derived Obesity Candidate Region on Chromosome 16p11.2

  2015cites this paper
• Physiological Modulation of the Reverse Cholesterol Transport Pathway in Vivo Reija Silvennoinen

  2015cites this paper
• Overexpression of JAZF1 protected ApoE-deficient mice from atherosclerosis by inhibiting hepatic cholesterol synthesis via CREB-dependent mechanisms.

  2014cites this paper
• Expression profiles of key transcription factors involved in lipid metabolism in Beijing-You chickens.

  2014cites this paper
• JAZF1 regulates visfatin expression in adipocytes via PPARα and PPARβ/δ signaling.

  2014cites this paper
• Effects of the C161T polymorphism in the gene of peroxisome proliferators activated receptor γ on changes of plasma lipid and apolipoprotein ratios induced by a high carbohydrate diet in a healthy Chinese Han young population.

  2014cites this paper
• Apolipoprotein B-48: a unique marker of chylomicron metabolism.

  2014cites this paper
• Effect of the PPARγ C161T Gene Variant on Serum Lipids in Ischemic Stroke Patients with and Without Type 2 Diabetes Mellitus

  2014cites this paper
• Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients

  2014cites this paper
• JAZF1 can regulate the expression of lipid metabolic genes and inhibit lipid accumulation in adipocytes.

  2014cites this paper
• Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.

  2014cites this paper
• Mechanism of action of natural compounds enhancing macrophage cholesterol efflux

  2013cites this paper
• The effects of dietary fatty acids on the postprandial triglyceride-rich lipoprotein/apoB48 receptor axis in human monocyte/macrophage cells.

  2013cites this paper
• Emerging roles of peroxisome proliferator-activated receptors in the pituitary gland in female reproduction

  2013cites this paper
• Mechanisms of bacteria-mediated lipid droplet formation in macrophages

  2013influential citation
• Nuclear receptor mediated mechanisms of macrophage cholesterol metabolism.

  2013cites this paper
• Postprandial lipoproteins and the molecular regulation of vascular homeostasis.

  2013cites this paper
• Biology and therapeutic applications of peroxisome proliferator- activated receptors.

  2012cites this paper
• Triglyceride-rich lipoprotein regulates APOB48 receptor gene expression in human THP-1 monocytes and macrophages.

  2012cites this paper
• Very-Low-Density Lipoprotein: Complex Particles in Cardiac Energy Metabolism

  2011cites this paper
• Peroxisome Proliferator-Activated Receptors and Atherosclerosis

  2011cites this paper
• PPARγ gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus

  2010cites this paper
• Genes and Nutrition

  2010cites this paper
• A novel model of cholesterol efflux from lipid-loaded cells

  2010cites this paper
• Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease.

  2009cites this paper
• Lipid ligand-activated transcription factors regulating lipid storage and release in human macrophages.

  2009cites this paper
• PPARs and the Cardiovascular System

  2009cites this paper
• An investigation of the atherogenicity of intermediate density lipoprotein in people with and without type 2 diabetes mellitus

  2009cites this paper
• Regulation of Macrophage Functions by PPAR-&agr;, PPAR-&ggr;, and LXRs in Mice and Men

  2008cites this paper
• The interaction of hepatitis C virus and intracellular lipid metabolism

  2008cites this paper
• Glitazones in the treatment of cardiovascular risk factors

  2007cites this paper
• Peroxisome proliferator‐activated receptors – from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease

  2007cites this paper
• The year in atherothrombosis.

  2007cites this paper
• Vascular effects of PPARgamma activators - from bench to bedside.

  2007cites this paper
• Perilipin and adipophilin expression in lipid loaded macrophages.

  2007cites this paper
• 山苦瓜改善高油高糖餵食大鼠腹部體脂堆積及胰島素抗性; Wild Bitter Melon Ameliorate Abdominal Fat Accumulation and Insulin Resistance in High Fat High Sugar Fed Rats

  2006cites this paper
• Transcriptional regulation of macrophage cholesterol trafficking by PPARalpha and LXR.

  2006cites this paper
• PPARγ and atherosclerosis

  2005cites this paper
• PPARgamma and atherosclerosis.

  2005cites this paper
• An overview on biological mechanisms of PPARs.

  2005cites this paper
• Differential uptake of subfractions of triglyceride-rich lipoproteins by THP-1 macrophages.

  2005cites this paper
• Pleiotropic effects of fibrates

  2005cites this paper
• Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes.

  2005cites this paper
• Rosiglitazone reduces insulin requirement and C-reactive protein levels in type 2 diabetic patients receiving peritoneal dialysis.

  2005cites this paper
• Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.

  2005cites this paper
• Expression in Vascular Cells Peroxisome Proliferator-Activated Receptors and Atherogenesis : Regulators of Gene

  2004cites this paper
• Direct effects of long-chain non-esterified fatty acids on vascular cells and their relevance to macrovascular complications of diabetes.

  2004cites this paper
• Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.

  2004cites this paper
• The role andmode of action of apolipoproteins CIII and AV: synergistic actors in triglyceridemetabolism Related review: The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism (pp 239–246)

  2004cites this paper
• Postprandial hyperlipidemia and atherosclerosis.

  2004cites this paper
• Pitavastatin Inhibits Remnant Lipoprotein-Induced Macrophage Foam Cell Formation Through ApoB48 Receptor–Dependent Mechanism

  2004cites this paper
• PPAR alpha, fibrates, lipid metabolism and inflammation.

  2004cites this paper
• Peroxisome proliferator-activated receptors: new targets for the pharmacological modulation of macrophage gene expression and function

  2003cites this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper